fibrotic disease | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

93,648 results for “fibrotic disease”

Trials

View all 70832 →

68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease

500 participants · First posted Apr 5, 2021

68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases

390 participants · First posted Feb 23, 2024

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

210 participants · First posted May 29, 2026

Drugs

View all 1505 →

small molecule therapeutics (fibrotic disease)

MC1R agonist (immune disease, fibrotic disease)

Fibrotic Diseases(Recursion)

Organizations

View all 170 →

Pliant Therapeutics

United States

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

News

View all 21141 →

Lantheus Partners with Pfizer and Lumina in FIBRE Consortium to Transform Fibrotic Disease Clinical Trials

Agomab Therapeutics Raises $200 Million in IPO to Advance Fibrotic Disease Therapies

Calluna Pharma's CAL101 Demonstrates Favorable Safety Profile in Phase 1 Trial for Fibrotic Diseases

Page 1 of 9365